Pembrolizumab vs Strontium Chloride Sr 89
Pembrolizumab vs Strontium Chloride Sr 89: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Strontium Chloride Sr 89.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days.
Chemical Properties
Type: Pembrolizumab β Antibody; Strontium Chloride Sr 89 β Small molecule.